Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis

被引:0
|
作者
Qu, Chen [1 ]
Zheng, Dandan [1 ]
Li, Sai [2 ]
Lidofsky, Anna [3 ]
Jiang, Yuchuan [1 ]
He, Lu [1 ]
Yuan, Hui [1 ]
Chen, Xijun [1 ]
Hu, Qiaoting [4 ]
Luo, Xiaojun [4 ]
Zhou, Yuchen [1 ]
Lin, Wenyu [3 ]
Chung, Raymond T. [3 ]
Hong, Jian [1 ,3 ]
机构
[1] Southern Med Univ, Dept Abdominal Surg, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Dept Pharm, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA USA
[4] Southern Med Univ, Dept Expt Res, Ctr Canc, Guangzhou, Guangdong, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
240
引用
收藏
页码:136A / 137A
页数:2
相关论文
共 50 条
  • [31] Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
    Buchner, Maike
    Fuchs, Simon
    Prinz, Gabriele
    Pfeifer, Dietmar
    Bartholome, Kilian
    Burger, Meike
    Chevalier, Nina
    Vallat, Laurent
    Timmer, Jens
    Gribben, John G.
    Jumaa, Hassan
    Veelken, Hendrik
    Dierks, Christine
    Zirlik, Katja
    CANCER RESEARCH, 2009, 69 (13) : 5424 - 5432
  • [32] RON receptor tyrosine kinase as a potential translational therapeutic target in malignant pleural mesothelioma
    Easty, D.
    Gray, S. G.
    Nonaka, D.
    Soltermann, A.
    Murer, B.
    Kennedy, M. J.
    Mutti, L.
    Pass, H. I.
    O'Donnell, D. M.
    O'Byrne, K. J.
    LUNG CANCER, 2010, 67 : S19 - S20
  • [33] 14-kDa phosphohistidine phosphatase is a potential therapeutic target for liver fibrosis
    Xu, Anjian
    Zhou, Jichao
    Li, Yanmeng
    Qiao, Luyao
    Jin, Caicai
    Chen, Wei
    Sun, Lan
    Wu, Shanna
    Li, Xiaojin
    Zhou, Donghu
    Jia, Siyu
    Zhang, Bei
    Yao, Jingyi
    Zhang, Xiaowei
    You, Hong
    Huang, Jian
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2021, 320 (03): : G351 - G365
  • [34] HMGB2: A Novel Regulator and Potential Therapeutic Target for Liver Fibrosis
    Huang, Yi
    Yang, Zhihong
    Shin, Dong-Ju
    Keshipeddy, Santosh K.
    Wright, Dennis
    Costa, Antonio
    Burgess, Diane
    Wang, Li
    FASEB JOURNAL, 2017, 31
  • [35] Syk as a therapeutic target for asthma
    Farmer, Luc J.
    Bemis, Guy
    Britt, Shawn D.
    Cochran, John
    Connors, Martin
    Harrington, Edmund M.
    Hoock, Thomas
    Markland, William
    Nanthakumar, Suganthini
    Taslimi, Paul
    Ter Haar, Ernst
    Wang, Jian
    Zhaveri, Darshana
    Salituro, Francesco G.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [36] Dual inhibition of reactive oxygen species and spleen tyrosine kinase as a therapeutic strategy in liver fibrosis
    Hu, Qiaoting
    Liu, Mingyu
    You, Yundan
    Zhou, Guo
    Chen, Ye
    Yuan, Hui
    Xie, Lulu
    Han, Shisong
    Zhu, Kangshun
    FREE RADICAL BIOLOGY AND MEDICINE, 2021, 175 : 193 - 205
  • [37] AXL receptor tyrosine kinase as a therapeutic target in NSCLC
    Okimoto, Ross A.
    Bivona, Trever G.
    LUNG CANCER-TARGETS AND THERAPY, 2015, 6 : 27 - 34
  • [38] Therapeutic potential of tyrosine kinase 2 in autoimmunity
    Liang, Yan
    Zhu, Yan
    Xia, Yi
    Peng, Hui
    Yang, Xiao-Ke
    Liu, Yan-Yan
    Xu, Wang-Dong
    Pan, Hai-Feng
    Ye, Dong-Qing
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (05) : 571 - 580
  • [39] Ron receptor tyrosine kinase signaling as a therapeutic target
    Benight, Nancy M.
    Waltz, Susan E.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (09) : 921 - 931
  • [40] MET receptor tyrosine kinase as a therapeutic anticancer target
    Stellrecht, Christine M.
    Gandhi, Varsha
    CANCER LETTERS, 2009, 280 (01) : 1 - 14